First United Bank & Trust Buys 1,030 Shares of CME Group Inc. $CME

Key Points

• First United Bank & Trust increased its stake in CME Group Inc. by 25.9%, acquiring an additional 1,030 shares, bringing its total holdings to 5,002 shares valued at approximately $1.38 million.
• CME Group reported $2.96 earnings per share in the last quarter, exceeding analyst estimates and showing a 10.4% year-over-year revenue increase.
• The company announced a quarterly dividend of $1.25 per share, representing a 1.8% yield with a payout ratio of 48.40%.

First United Bank & Trust boosted its position in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 25.9% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 5,002 shares of the financial services provider's stock after acquiring an additional 1,030 shares during the quarter. First United Bank & Trust's holdings in CME Group were worth $1,379,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Wayfinding Financial LLC purchased a new stake in CME Group during the first quarter valued at approximately $25,000. Webster Bank N. A. boosted its position in shares of CME Group by 206.9% in the second quarter. Webster Bank N. A. now owns 89 shares of the financial services provider's stock worth $25,000 after purchasing an additional 60 shares during the period. Cornerstone Planning Group LLC raised its position in shares of CME Group by 122.2% during the 1st quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider's stock valued at $26,000 after purchasing an additional 55 shares during the period. Highline Wealth Partners LLC lifted its stake in shares of CME Group by 84.3% during the 2nd quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider's stock valued at $26,000 after buying an additional 43 shares in the last quarter. Finally, Golden State Wealth Management LLC boosted its holdings in CME Group by 612.5% in the 1st quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider's stock worth $30,000 after buying an additional 98 shares during the period. 87.75% of the stock is owned by hedge funds and other institutional investors.

CME Group Stock Up 0.7%

Shares of CME opened at $272.24 on Tuesday. CME Group Inc. has a 52-week low of $213.94 and a 52-week high of $290.79. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. The business has a fifty day moving average of $270.81 and a 200 day moving average of $271.14. The company has a market cap of $98.11 billion, a PE ratio of 26.35, a P/E/G ratio of 4.89 and a beta of 0.43.

CME Group (NASDAQ:CME - Get Free Report) last posted its quarterly earnings data on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share for the quarter, topping analysts' consensus estimates of $2.91 by $0.05. The company had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.68 billion. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The firm's revenue for the quarter was up 10.4% on a year-over-year basis. During the same period in the prior year, the company posted $2.56 EPS. On average, sell-side analysts expect that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, September 25th. Shareholders of record on Tuesday, September 9th were paid a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a yield of 1.8%. The ex-dividend date was Tuesday, September 9th. CME Group's dividend payout ratio is currently 48.40%.

Insider Transactions at CME Group

In other CME Group news, Director William R. Shepard acquired 262 shares of the stock in a transaction that occurred on Thursday, September 25th. The stock was bought at an average cost of $265.19 per share, with a total value of $69,479.78. Following the completion of the purchase, the director directly owned 258,459 shares in the company, valued at $68,540,742.21. The trade was a 0.10% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Sunil Cutinho sold 11,896 shares of the stock in a transaction dated Tuesday, August 26th. The stock was sold at an average price of $271.47, for a total transaction of $3,229,407.12. Following the transaction, the insider owned 17,440 shares in the company, valued at approximately $4,734,436.80. The trade was a 40.55% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 13,043 shares of company stock worth $3,527,956 in the last ninety days. 0.30% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on CME shares. Piper Sandler boosted their price objective on CME Group from $283.00 to $296.00 and gave the company an "overweight" rating in a research report on Tuesday, July 15th. Barclays set a $298.00 price target on CME Group and gave the stock an "equal weight" rating in a report on Thursday, July 24th. Wall Street Zen lowered shares of CME Group from a "hold" rating to a "sell" rating in a report on Sunday, July 13th. UBS Group reduced their price objective on shares of CME Group from $305.00 to $285.00 and set a "neutral" rating on the stock in a research report on Monday, September 8th. Finally, Citigroup upgraded shares of CME Group from a "neutral" rating to a "buy" rating and upped their target price for the stock from $275.00 to $300.00 in a research report on Thursday, September 25th. Five investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and three have issued a Sell rating to the company. According to MarketBeat, CME Group presently has a consensus rating of "Hold" and an average target price of $268.14.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.